Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-02 @ 4:30 AM
Study NCT ID:
NCT04246359
Status:
UNKNOWN
Last Update Posted:
2022-04-07
First Post:
2020-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma
Sponsor:
Huiqiang Huang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01-16
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-14
First Submit QC Date:
None
Study First Post Date:
2020-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-06
Last Update Post Date:
2022-04-07
Last Update Post Date Type:
ACTUAL